Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Trends Pharmacol Sci. 2017 Feb 14;38(4):339–362. doi: 10.1016/j.tips.2017.01.004

Figure 2. Chemical structures of antivirulence compounds discussed in this review.

Figure 2

Small molecules that inhibit: A. Two-component regulatory systems; B. Bacterial adherence; C. Toxins and secretion systems; and D. Metabolic pathways required for virulence.